B.C.G. immunotherapy in carcinoma of prostate.
作者信息
Guinan P, Bush I M, John T, Sadoughi N, Ablin R J
出版信息
Lancet. 1973 Aug 25;2(7826):443-4. doi: 10.1016/s0140-6736(73)92302-7.
PMID:4124919
Abstract
摘要
相似文献
1
B.C.G. immunotherapy in carcinoma of prostate.
Lancet. 1973 Aug 25;2(7826):443-4. doi: 10.1016/s0140-6736(73)92302-7.
2
Prostate carcinoma: immunostaging and adjuvant immunotherapy with BCG.前列腺癌：免疫分期及卡介苗辅助免疫治疗
Natl Cancer Inst Monogr. 1978 Dec(49):355-60.
3
BCG adjuvant immunotherapy in carcinoma of the prostate: an interim report.卡介苗辅助免疫疗法治疗前列腺癌：中期报告
Allergol Immunopathol (Madr). 1978 Jul-Aug;6(4):293-6.
4
Adjuvant immunotherapy (BCG) in stage D prostate cancer.D期前列腺癌的辅助免疫治疗（卡介苗）
Am J Clin Oncol. 1982 Feb;5(1):65-8.
5
Immunotherapy by BCG against prostate adenocarcinomas in anatomical compartments.卡介苗针对解剖学分区前列腺腺癌的免疫疗法。
Anticancer Res. 1994 Nov-Dec;14(6B):2691-4.
6
Adjuvant immunotherapy with B.C.G. in carcinoma of the prostate.卡介苗辅助免疫疗法治疗前列腺癌。
Br J Urol. 1977 Jun;49(3):221-6. doi: 10.1111/j.1464-410x.1977.tb04108.x.
7
Immunotherapy of prostatic carcinoma with bacillus Calmette-Guerin.卡介苗对前列腺癌的免疫治疗
Cancer Chemother Rep. 1975 Jan-Feb;59(1):157-63.
8
The new aspects of immunotherapy in prostate cancer.前列腺癌免疫治疗的新进展
Cancer Immunol Immunother. 2012 Dec;61(12):2375-6. doi: 10.1007/s00262-012-1309-2. Epub 2012 Jun 27.
9
Update on the treatment of cancer with multiple immunotherapy.多种免疫疗法治疗癌症的最新进展
Cancer Biother Radiopharm. 1999 Feb;14(1):27-30. doi: 10.1089/cbr.1999.14.27.
10
Vitamin D-binding protein-derived macrophage-activating factor, GcMAF, and prostate cancer.维生素D结合蛋白衍生的巨噬细胞激活因子、GcMAF与前列腺癌
Cancer Immunol Immunother. 2012 Dec;61(12):2377-8. doi: 10.1007/s00262-012-1310-9. Epub 2012 Jun 28.
Zotero 插件